Recently, there has been significant interest in anti-obesity medications (AOMs) from the general public, employers, and access stakeholders. In an effort to provide decision-makers like you with information you may need when considering a weight-management approach for your employees or members, we have created these sample Q&As. The topics covered include:

• Part 1: Impact of Weight Loss
• Part 2: AOMs for the Treatment of Obesity or Overweight

• • Section 1: Your Population and AOMs
  • Section 2: The Evolution of AOM Coverage
  • Section 3: Integrating AOMs Into Your Organization’s Weight-Management Approach

Obesity and associated comorbidities are a prevalent and costly chronic condition that can impact the health of your employees and your organization. Novo Nordisk recognizes the challenges in the workplace created by obesity and aims to help employers understand the value of chronic weight management